-
Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Severe COVID-19 Patients
firstwordpharma
August 27, 2021
Airway Therapeutics, Inc. (Airway) announced dosing of the first patient on August 17, 2021 in the AT-100 (rhSP-D) Phase 1b trial in mechanically-ventilated COVID-19 patients.
-
US ships more than 2 mln more Covid vaccines to Africa
firstwordpharma
August 27, 2021
The White House said Thursday that the US is shipping more than 2 million doses of COVID-19 vaccines to Algeria, Ghana and Yemen, as reported This is Money.
-
CytoDyn Appoints Seenu Srinivasan as Executive Director of CMC Regulatory Affairs
firstwordpharma
August 27, 2021
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company") announced today the appointment of Seenu Srinivasan, Ph.D., as Executive Director-CMC Regulatory Affairs.
-
Electric Vehicle Sourcing and Procurement Market by 2024 | COVID-19 Impact & Recovery Analysis | SpendEdge
prnewswire
August 27, 2021
The Electric Vehicle market is poised to grow by USD 275.22 Billion, progressing at a CAGR of almost 20.39% during the forecast period.
-
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
prnewswire
August 27, 2021
RedHill Biopharma Ltd. today announced preliminary results of a new preclinical study showing strong inhibition by opaganib (ABC294640)[1] of Delta variant replication while maintaining cell viability at relevant concentrations.
-
PURO Air's Aurora UV Air Fan Proven 99.976% Effective Against Eradicating the Virus That Causes COVID-19 (Including Delta-Variant)
prnewswire
August 27, 2021
PURO™ UV Disinfection Lighting announces today the results of an independent lab test proving its PURO Air Aurora UV Air Fan, offering continuous air disinfection, is effective in inactivating aerosolized SARS-CoV-2.
-
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800
prnewswire
August 27, 2021
INOVIO today announced that it has received regulatory authorization from Brazil's ANVISA (Agência Nacional de Vigilância Sanitária), the national health regulatory agency of Brazil, to initiate the global Phase 3 segment of its Phase 2/3 trial.
-
LOTTE HOTELS&RESORTS ready for global travelers with special services facing COVID-19
prnewswire
August 27, 2021
Travel industry is moving fast as travel expectations rise, striving to meet customers' post-pandemic needs for stricter hygiene and safety, and provide services accordingly.
-
Colombia says welcome back to all cruises!
prnewswire
August 27, 2021
The return of international cruise lines to Colombia is a reality. On Tuesday August 24th, the first cruise docked at the Port of Cartagena, after more than a year and a half without shipping companies arriving in Colombia.
-
Long COVID, Big Bills: Grim Legacy of Even Short Hospital Stays
drugs
August 26, 2021
When COVID-19 patients are discharged from the hospital, most are far from being well -- even if their hospital stay was fairly short.